Tetrahydro-naphthols as orally available TRPV1 inhibitors-Reference-Cited by-同舟云学术

Tetrahydro-naphthols as orally available TRPV1 inhibitors

Published:2012-05 Issue:10 Volume:22 Page:3408-3411
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Urbahns Klaus,Yura Takeshi,Gupta Jang B.,Tajimi Masaomi,Fujishima Hiroshi,Masuda Tsutomu,Yamamoto Noriyuki,Ikegami Yuka,Marumo Makiko,Yasoshima Kayo,Yoshida Nagahiro,Moriwaki Toshiya,Madge David,Chan Fiona,Mogi Muneto

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference22 articles.

1. Transient receptor potential channels as therapeutic targets

2. TRP channels: Emerging targets for respiratory disease

3. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

4. Analgesic potential of TRPV1 antagonists

5. N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure–activity relationships in the A-region

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain;European Journal of Medicinal Chemistry;2023-01

2. Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain;European Journal of Medicinal Chemistry;2019-11

3. Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists;Medicinal Research Reviews;2016-12-15

4. Discovery of novel pyrrolopyridazine scaffolds as transient receptor potential vanilloid (TRPV1) antagonists;Bioorganic & Medicinal Chemistry Letters;2012-11